NCT04135508View on ClinicalTrials.gov

A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

PHASE3CompletedINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

December 13, 2016

Primary Completion Date

March 22, 2018

Study Completion Date

May 31, 2018

Conditions
Ankylosing Spondylitis
Interventions
DRUG

BAT1406

40mg/0.8ml

DRUG

Humira

40mg/0.8ml

Sponsors
All Listed Sponsors
lead

Bio-Thera Solutions

INDUSTRY